Conversely, VitD administration in rats with NAFLD markedly (p < 0.05) normalized ALT and ALP serum activities and caused a substantial (p < 0.05) decrease in serum AST activity but did not return it to its normal value, suggesting that VitD has hepatoprotective properties. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.